Two instances of coronavirus infection in patients who had had the virus have been reported in Europe.
The information follows the initial confirmation of an instance of COVID-19 reinfection at a guy in Hong Kong, that tested positive twice for the illness.
As stated by the University of Hong Kong, the guy was reinfected four-and-a-half weeks following his very first disease, indicating the disorder can infect numerous occasions.
It had been reported by Dutch broadcaster NOS along with the finding that has been supported to Euronews on the telephone by a spokesperson at Erasmus MC.
Belgian broadcaster VRT also reported an instance of reinfection was verified in Belgium. It had been claimed by virologist Marc Van Ranst, who stated”it isn’t great news”.
“There are enough gaps to have the ability to talk of another breed, another disease,” he explained of this situation that concerns a woman from the city of Leuven, that had been reinfected three weeks following her very first instance of COVID-19.
‘It was just a matter of time’
Pros have responded with caution to the findings since it remains to be seen when those are rare circumstances.
An infectious diseases doctor and epidemiologist, Dr. Isaac Bogoch, advised Euronews we shouldn’t always be concerned with the information.
“We knew this was bound to occur, it was just a matter of time, we surely have one plausible case today, there could be a couple of other people, and we’re likely to see more,” he explained.
“I think what is promising today, we have seen at least together with the situation in Hong Kong, whoever was reinfected, this person had no symptoms at all.”
This implies that his immune system is probably successfully fighting off the disease once it experiences it for another time, he explained.
“We expect that’s a lasting trend in people that are reinfected,” he added.
Dr. Bogoch was cautious about these findings that could influence the search for a vaccine. He contended that if a vaccine does not provide 100% protection against disease, so long as it mitigates the disease somewhat it might prove to save the lives of the most vulnerable to COVID-19.